Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spero Therapeutics Inc.

0.7542
+0.01421.92%
Post-market: 0.75420.00000.00%17:33 EDT
Volume:35.94K
Turnover:27.62K
Market Cap:42.16M
PE:-0.59
High:0.7860
Open:0.7400
Low:0.7400
Close:0.7400
Loading ...
Jun 04, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Major Issues Report

8-K/A [Amend] - Current report
May 08, 2020

Major Issues Report

Current report, items 2.02 and 9.01
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 16, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Mar 19, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 16, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2020

Major Issues Report

8-K - Current report
Feb 28, 2020

Major Issues Report

Current report, items 3.03, 5.03, 8.01, and 9.01
Feb 18, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 30, 2020

Major Issues Report

Current report, items 1.01, 3.02, 8.01, and 9.01
Dec 19, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Dec 05, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 04, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 04, 2019

Major Issues Report

Current report, items 2.02 and 9.01